In such cases fast reopening of the infarct vessel is the main aim of treatment. This ‘reperfusion’ therapy has been proven to save lives, especially when applied with 2-3 hours following the onset of infarction. Recanalisation of the infarct vessel can be obtained by administering thrombolytic agents or by carrying out a mechanical recanalisation accompanied by angioplasty of the culprit lesion . Primary PCI can open more vessels than thrombolytic therapy considerably, and save even more lives as a result, but it can only just be performed in services with a cath laboratory and an experienced team on stand-by. Getting sufferers with an AMI to a PCI centre in the shortest possible time is a significant challenge which requires a close collaboration between cardiologists of different hospitals and the emergency medical system.Thus Turner’s team tested a pharmaceutical-grade version among 119 older adults with slight to moderate Alzheimer’s. All were already taking standard medications for slowing the disease’s progression. About 50 percent the sufferers were randomly assigned to include resveratrol capsules, while the rest received placebo capsules. Over twelve months, the resveratrol group showed a stabilization in the level of a proteins – – called amyloid-beta 40 – – in their spinal fluid. On the other hand, those known levels declined in the placebo group. That’s essential, Hendrix explained, because degrees of amyloid-beta 40 in the spinal fluid normally lower as Alzheimer’s worsens.